UC160
4-羟基甲苯磺丁脲
≥98% (HPLC)
别名:
N-(丁基氨基甲酰)-4-羟甲基苯磺酰胺
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C12H18N2O4S
化学文摘社编号:
分子量:
286.35
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12161501
MDL number:
产品名称
4-羟基甲苯磺丁脲, ≥98% (HPLC)
InChI
1S/C12H18N2O4S/c1-2-3-8-13-12(16)14-19(17,18)11-6-4-10(9-15)5-7-11/h4-7,15H,2-3,8-9H2,1H3,(H2,13,14,16)
SMILES string
CCCCNC(=O)NS(=O)(=O)c1ccc(CO)cc1
InChI key
SJRHYONYKZIRPM-UHFFFAOYSA-N
assay
≥98% (HPLC)
form
solid
color
white
mp
100-102 °C
solubility
ethanol: soluble 12 mg/mL
0.1 M NaOH: soluble 4 mg/mL
H2O: insoluble
storage temp.
2-8°C
正在寻找类似产品? 访问 产品对比指南
Packaging
无底玻璃瓶。内含物装在插入式熔锥内。
Application
4-羟基甲苯磺丁脲已用作标准品，用于测定从甲苯磺丁脲到4'-羟基甲苯磺丁脲的真菌生物转化。
Other Notes
甲苯磺丁脲的代谢物；通过 P450 酶的细胞色素 CYP2CIIC8 和 IIC9 亚家族形成。
Preparation Note
4-羟基甲苯磺丁脲可溶于乙醇（浓度为 12 mg/mL），也可溶于 0.1 MNaOH（浓度为 4 mg/mL）。它不溶于水。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Biotransformation of tolbutamide to 4'-hydroxytolbutamide by the fungus Cunninghamella blakesleeana.
Haihua Huang et al.
Applied microbiology and biotechnology, 72(3), 486-491 (2006-02-24)
The hypoglycemic drug tolbutamide is commonly used as a probe drug to evaluate CYP2C9 enzyme activity in terms of production of 4'-hydroxytolbutamide. In the present study, an initial screening of seven filamentous fungi was carried out to identify which was
D J Back et al.
British journal of pharmacology, 85(1), 121-126 (1985-05-01)
Tolbutamide has been used as a model drug for an examination of the effects of eleven substituted imidazole compounds on hepatic metabolism in vivo. The 1-substituted compounds 1-methylimidazole, miconazole, clotrimazole and ketoconazole produced marked alterations in tolbutamide kinetics (increased half-life
Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9.
J O Miners et al.
Methods in enzymology, 272, 139-145 (1996-01-01)
Julia Kirchheiner et al.
Pharmacogenetics, 12(2), 101-109 (2002-03-05)
Tolbutamide is known to be metabolized by cytochrome P450 2C9 (CYP2C9), and the effects of the CYP2C9 amino acid polymorphisms *2 (Arg144Cys) and *3 (Ile359Leu) could be important for drug treatment with tolbutamide and for use of tolbutamide as a
Ji-Hong Shon et al.
Pharmacogenetics, 12(2), 111-119 (2002-03-05)
Several recent in-vitro data have revealed that CYP2C19, in addition to CYP2C9, is also involved in the 4-methylhydroxylation of tolbutamide. We evaluated the relative contribution of CYP2C9 and CYP2C19 genetic polymorphisms on the disposition of blood glucose lowering response to
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持